Seer to Present at the Cowen 42nd Annual Health Care Conference

Rhea-AI Summary

Seer, a life sciences company specializing in proteomics, has announced its virtual participation in the Cowen 42nd Annual Health Care Conference scheduled for March 8, 2022. The company's management will engage in a fireside chat at 11:50 a.m. Pacific Time. Interested investors can access a live webcast on Seer’s investor website, with an archived replay available afterward. Seer’s Proteograph Product Suite enables deep proteomic analysis efficiently and is designed for research use only, aiming to enhance laboratory capabilities.

REDWOOD CITY, Calif., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced that the company will be participating virtually in the upcoming Cowen 42^nd Annual Health Care Conference.

Seer’s management is scheduled to participate in a fireside chat on Tuesday, March 8 at 11:50 a.m. Pacific Time / 2:50 p.m. Eastern Time. A live webcast of the virtual session will be available on the Investor section of Seer’s website at investor.seer.bio. An archived replay will be available on the company’s website following the conference.

About Seer

Seer™ is a life sciences company developing transformative products that open a new gateway to the proteome. Seer’s Proteograph™ Product Suite is an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation and software to perform deep, unbiased proteomic analysis at scale in a matter of hours. Seer designed the Proteograph workflow to be efficient and easy to use, leveraging widely adopted laboratory instrumentation to provide a decentralized solution that can be incorporated by nearly any lab. Seer’s Proteograph Product Suite is for research use only and is not intended for diagnostic procedures. For more information, please visit www.seer.bio.

Investor Contact
Carrie Mendivil
investor@seer.bio

Media Contact
Karen Possemato
pr@seer.bio

FAQ

When is Seer participating in the Cowen 42nd Annual Health Care Conference?

Seer will participate in the Cowen 42nd Annual Health Care Conference on March 8, 2022.

What time will Seer's management participate in the fireside chat?

Seer's management is scheduled to participate in the fireside chat at 11:50 a.m. Pacific Time.

Where can I watch Seer's fireside chat from the conference?

You can watch Seer's fireside chat live on their investor website at investor.seer.bio.

What is Seer’s Proteograph Product Suite?

Seer’s Proteograph Product Suite is an integrated solution for deep, unbiased proteomic analysis designed for research use only.

Is Seer's Proteograph Product Suite intended for diagnostic procedures?

No, Seer's Proteograph Product Suite is not intended for diagnostic procedures; it is for research use only.